Understanding Trastuzumab Biosimilars: Market Dynamics and Growth Prospects in 2024 Trastuzumab and its Role in Oncology
Trastuzumab, marketed under brand names like Herceptin, is a monoclonal antibody used primarily in the treatment of HER2-positive breast cancer and other HER2-positive cancers. It has significantly improved outcomes for patients by targeting the HER2 protein overexpressed in these cancers, thereby inhibiting tumor growth and reducing the risk of recurrence....
0 Поделились
137 Просмотры
0 предпросмотр